Friday, July 4, 2014

DMEMEDS shared post via Reuters: Acorda's multiple sclerosis drug faces generic threat

(Reuters) - Acorda Therapeutics Inc said Actavis Plc plans to market a generic version of Acorda's multiple sclerosis treatment, Ampyra. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/lDMMJygD234/story01.htm

Read More

No comments:

Post a Comment

Subscribe Now: Feed Icon